pmc logo image
Logo of cmajCMAJ Information for AuthorsCMAJ Home Page
Journal List > CMAJ > v.144(4); Feb 15, 1991

Formats:
CMAJ. 1991 February 15; 144(4): 425–431.
PMCID: PMC1452799
Copyright notice
Periodic health examination, 1991 update: 1. Screening for cognitive impairment in the elderly. Canadian Task Force on the Periodic Health Examination.
Small right arrow pointing to: See letter "Screening for cognitive impairment in the elderly." on page 1605.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.7M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
icon of scanned page 425
425
icon of scanned page 426
426
icon of scanned page 427
427
icon of scanned page 428
428
icon of scanned page 429
429
icon of scanned page 430
430
icon of scanned page 431
431
 
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • KAY DW, BEAMISH P, ROTH M. OLD AGE MENTAL DISORDERS IN NEWCASTLE UPON TYNE. I. A STUDY OF PREVALENCE. Br J Psychiatry. 1964 Mar;110:146–158. [PubMed]
  • Broe GA, Akhtar AJ, Andrews GR, Caird FI, Gilmore AJ, McLennan WJ. Neurological disorders in the elderly at home. J Neurol Neurosurg Psychiatry. 1976 Apr;39(4):362–366. [PubMed]
  • Weissman MM, Myers JK, Tischler GL, Holzer CE, 3rd, Leaf PJ, Orvaschel H, Brody JA. Psychiatric disorders (DSM-III) and cognitive impairment among the elderly in a U.S. urban community. Acta Psychiatr Scand. 1985 Apr;71(4):366–379. [PubMed]
  • Kay DW, Henderson AS, Scott R, Wilson J, Rickwood D, Grayson DA. Dementia and depression among the elderly living in the Hobart community: the effect of the diagnostic criteria on the prevalence rates. Psychol Med. 1985 Nov;15(4):771–788. [PubMed]
  • Kay DW, Bergmann K, Foster EM, McKechnie AA, Roth M. Mental illness and hospital usage in the elderly: a random sample followed up. Compr Psychiatry. 1970 Jan;11(1):26–35. [PubMed]
  • Campbell AJ, McCosh LM, Reinken J, Allan BC. Dementia in old age and the need for services. Age Ageing. 1983 Feb;12(1):11–16. [PubMed]
  • Hagnell O, Lanke J, Rorsman B, Ojesjö L. Does the incidence of age psychosis decrease? A prospective, longitudinal study of a complete population investigated during the 25-year period 1947-1972: the Lundby study. Neuropsychobiology. 1981;7(4):201–211. [PubMed]
  • Hagnell O, Lanke J, Rorsman B, Ohman R, Ojesjö L. Current trends in the incidence of senile and multi-infarct dementia. A prospective study of a total population followed over 25 years; the Lundby Study. Arch Psychiatr Nervenkr. 1983;233(6):423–438. [PubMed]
  • Johnson RT, Price DL. Chronic neurological diseases: their societal burdens and potential solutions. J Chronic Dis. 1980;33(3):129–133. [PubMed]
  • Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand. 1987 Nov;76(5):465–479. [PubMed]
  • McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 Jul;34(7):939–944. [PubMed]
  • Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry. 1968 Jul;114(512):797–811. [PubMed]
  • Kokmen E, Naessens JM, Offord KP. A short test of mental status: description and preliminary results. Mayo Clin Proc. 1987 Apr;62(4):281–288. [PubMed]
  • Pattie AH, Gilleard CJ. A brief psychogeriatric assessment schedule. Validation against psychiatric diagnosis and discharge from hospital. Br J Psychiatry. 1975 Nov;127:489–493. [PubMed]
  • Jacobs JW, Bernhard MR, Delgado A, Strain JJ. Screening for organic mental syndromes in the medically ill. Ann Intern Med. 1977 Jan;86(1):40–46. [PubMed]
  • Omer H, Foldes J, Toby M, Menczel J. Screening for cognitive deficits in a sample of hospitalized geriatric patients: a re-evaluation of a brief mental status questionnaire. J Am Geriatr Soc. 1983 May;31(5):266–268. [PubMed]
  • Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc. 1975 Oct;23(10):433–441. [PubMed]
  • Wolber G, Romaniuk M, Eastman E, Robinson C. Validity of the Short Portable Mental Status Questionnaire with elderly psychiatric patients. J Consult Clin Psychol. 1984 Aug;52(4):712–713. [PubMed]
  • Smyer MA, Hofland BF, Jonas EA. Validity study of the short portable mental status questionnaire for the elderly. J Am Geriatr Soc. 1979 Jun;27(6):263–269. [PubMed]
  • Erkinjuntti T, Sulkava R, Wikström J, Autio L. Short Portable Mental Status Questionnaire as a screening test for dementia and delirium among the elderly. J Am Geriatr Soc. 1987 May;35(5):412–416. [PubMed]
  • Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H. Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. Am J Psychiatry. 1983 Jun;140(6):734–739. [PubMed]
  • Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–198. [PubMed]
  • Anthony JC, LeResche L, Niaz U, von Korff MR, Folstein MF. Limits of the 'Mini-Mental State' as a screening test for dementia and delirium among hospital patients. Psychol Med. 1982 May;12(2):397–408. [PubMed]
  • Dick JP, Guiloff RJ, Stewart A, Blackstock J, Bielawska C, Paul EA, Marsden CD. Mini-mental state examination in neurological patients. J Neurol Neurosurg Psychiatry. 1984 May;47(5):496–499. [PubMed]
  • DePaulo JR, Jr, Folstein MF. Psychiatric disturbances in neurological patients: detection, recognition, and hospital course. Ann Neurol. 1978 Sep;4(3):225–228. [PubMed]
  • Folstein M, Anthony JC, Parhad I, Duffy B, Gruenberg EM. The meaning of cognitive impairment in the elderly. J Am Geriatr Soc. 1985 Apr;33(4):228–235. [PubMed]
  • Magaziner J, Bassett SS, Hebel JR. Predicting performance on the Mini-Mental State Examination. Use of age- and education-specific equations. J Am Geriatr Soc. 1987 Nov;35(11):996–1000. [PubMed]
  • Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry. 1987 Aug;48(8):314–318. [PubMed]
  • Hodkinson HM. Evaluation of a mental test score for assessment of mental impairment in the elderly. Age Ageing. 1972 Nov;1(4):233–238. [PubMed]
  • Isaacs B, Akhtar AJ. The set test: a rapid test of mental function in old people. Age Ageing. 1972 Nov;1(4):222–226. [PubMed]
  • KAHN RL, GOLDFARB AI, POLLACK M, PECK A. Brief objective measures for the determination of mental status in the aged. Am J Psychiatry. 1960 Oct;117:326–328. [PubMed]
  • Fillenbaum GG, Heyman A, Wilkinson WE, Haynes CS. Comparison of two screening tests in Alzheimer's disease. The correlation and reliability of the Mini-Mental State Examination and the modified Blessed test. Arch Neurol. 1987 Sep;44(9):924–927. [PubMed]
  • Kiernan RJ, Mueller J, Langston JW, Van Dyke C. The Neurobehavioral Cognitive Status Examination: a brief but quantitative approach to cognitive assessment. Ann Intern Med. 1987 Oct;107(4):481–485. [PubMed]
  • Winograd CH. Mental status tests and the capacity for self-care. J Am Geriatr Soc. 1984 Jan;32(1):49–55. [PubMed]
  • Skurla E, Rogers JC, Sunderland T. Direct assessment of activities of daily living in Alzheimer's disease. A controlled study. J Am Geriatr Soc. 1988 Feb;36(2):97–103. [PubMed]
  • Warren EJ, Grek A, Conn D, Herrmann N, Icyk E, Kohl J, Silberfeld M. A correlation between cognitive performance and daily functioning in elderly people. J Geriatr Psychiatry Neurol. 1989 Apr–Jun;2(2):96–100. [PubMed]
  • Marsden CD, Harrison MJ. Outcome of investigation of patients with presenile dementia. Br Med J. 1972 Apr 29;2(5808):249–252. [PubMed]
  • Smith JS, Kiloh LG. The investigation of dementia: results in 200 consecutive admissions. Lancet. 1981 Apr 11;1(8224):824–827. [PubMed]
  • Clarfield AM. The reversible dementias: do they reverse? Ann Intern Med. 1988 Sep 15;109(6):476–486. [PubMed]
  • Larson EB, Reifler BV, Featherstone HJ, English DR. Dementia in elderly outpatients: a prospective study. Ann Intern Med. 1984 Mar;100(3):417–423. [PubMed]
  • Larson EB, Reifler BV, Sumi SM, Canfield CG, Chinn NM. Diagnostic evaluation of 200 elderly outpatients with suspected dementia. J Gerontol. 1985 Sep;40(5):536–543. [PubMed]
  • Little A, Levy R, Chuaqui-Kidd P, Hand D. A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1985 Aug;48(8):736–742. [PubMed]
  • Kaye WH, Sitaram N, Weingartner H, Ebert MH, Smallberg S, Gillin JC. Modest facilitation on memory in dementia with combined lecithin and anticholinerestase treatment. Biol Psychiatry. 1982 Feb;17(2):275–280. [PubMed]
  • Caltagirone C, Gainotti G, Masullo C. Oral administration of chronic physostigmine does not improve cognitive or mnesic performances in Alzheimer's presenile dementia. Int J Neurosci. 1982 May;16(3-4):247–249. [PubMed]
  • Mohs RC, Davis BM, Johns CA, Mathé AA, Greenwald BS, Horvath TB, Davis KL. Oral physostigmine treatment of patients with Alzheimer's disease. Am J Psychiatry. 1985 Jan;142(1):28–33. [PubMed]
  • Thal LJ, Fuld PA, Masur DM, Sharpless NS. Oral physostigmine and lecithin improve memory in Alzheimer disease. Ann Neurol. 1983 May;13(5):491–496. [PubMed]
  • Beller SA, Overall JE, Swann AC. Efficacy of oral physostigmine in primary degenerative dementia. A double-blind study of response to different dose level. Psychopharmacology (Berl). 1985;87(2):147–151. [PubMed]
  • Jotkowitz S. Lack of clinical efficacy of chronic oral physostigmine in Alzheimer's disease. Ann Neurol. 1983 Dec;14(6):690–691. [PubMed]
  • Stern Y, Sano M, Mayeux R. Effects of oral physostigmine in Alzheimer's disease. Ann Neurol. 1987 Sep;22(3):306–310. [PubMed]
  • Davis KL, Mohs RC, Davis BM, Horvath TB, Greenwald BS, Rosen WG, Levy MI, Johns CA. Oral physostigmine in Alzheimer's disease. Psychopharmacol Bull. 1983;19(3):451–453. [PubMed]
  • Molloy DW, Cape RD. Acute effects of oral pyridostigmine on memory and cognitive function in SDAT. Neurobiol Aging. 1989 Mar–Apr;10(2):199–204. [PubMed]
  • Bruno G, Mohr E, Gillespie M, Fedio P, Chase TN. Muscarinic agonist therapy of Alzheimer's disease. A clinical trial of RS-86. Arch Neurol. 1986 Jul;43(7):659–661. [PubMed]
  • Hollander E, Davidson M, Mohs RC, Horvath TB, Davis BM, Zemishlany Z, Davis KL. RS 86 in the treatment of Alzheimer's disease: cognitive and biological effects. Biol Psychiatry. 1987 Sep;22(9):1067–1078. [PubMed]
  • Summers WK, Majovski LV, Marsh GM, Tachiki K, Kling A. Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. N Engl J Med. 1986 Nov 13;315(20):1241–1245. [PubMed]
  • Molloy DW, Guyatt GH, Wilson DB, Duke R, Rees L, Singer J. Effect of tetrahydroaminoacridine on cognition, function and behaviour in Alzheimer's disease. CMAJ. 1991 Jan 1;144(1):29–34. [PubMed]
  • Rao DB, Norris JR. A double-blind investigation of hydergine in the treatment of cerebrovascular insufficiency in the elderly. Johns Hopkins Med J. 1972 May;130(5):317–324. [PubMed]
  • Bazo AJ. An ergot alkaloid preparation (Hydergine) versus papaverine in treating common complaints of the aged: double-blind study. J Am Geriatr Soc. 1973 Feb;21(2):63–71. [PubMed]
  • Jennings WG. An ergot alkaloid preparation (hydergine) versus placebo for treatment of symptoms of cerebrovascular insufficiency: double-blind study. J Am Geriatr Soc. 1972 Aug;20(8):407–412. [PubMed]
  • van Loveren-Huyben CM, Engelaar HF, Hermans MB, van der Bom JA, Leering C, Munnichs JM. Double-blind clinical and psychologic study of ergoloid mesylates (Hydergine) in subjects with senile mental deterioration. J Am Geriatr Soc. 1984 Aug;32(8):584–588. [PubMed]
  • Thienhaus OJ, Wheeler BG, Simon S, Zemlan FP, Hartford JT. A controlled double-blind study of high-dose dihydroergotoxine mesylate (Hydergine) in mild dementia. J Am Geriatr Soc. 1987 Mar;35(3):219–223. [PubMed]
  • Yesavage JA, Hollister LE, Burian E. Dihydroergotoxine: 6-mg versus 3-mg dosage in the treatment of senile dementia. Preliminary report. J Am Geriatr Soc. 1979 Feb;27(2):80–82. [PubMed]
  • Lipowski ZJ. Delirium in the elderly patient. N Engl J Med. 1989 Mar 2;320(9):578–582. [PubMed]
  • Koponen H, Stenbäck U, Mattila E, Soininen H, Reinikainen K, Riekkinen PJ. Delirium among elderly persons admitted to a psychiatric hospital: clinical course during the acute stage and one-year follow-up. Acta Psychiatr Scand. 1989 Jun;79(6):579–585. [PubMed]
  • Larson EB, Kukull WA, Buchner D, Reifler BV. Adverse drug reactions associated with global cognitive impairment in elderly persons. Ann Intern Med. 1987 Aug;107(2):169–173. [PubMed]
  • Ray DC, Raciti MA, Ford CV. Ageism in psychiatrists: associations with gender, certification, and theoretical orientation. Gerontologist. 1985 Oct;25(5):496–500. [PubMed]
  • Cyrus-Lutz C, Gaitz CM. Psychiatrists' attitudes toward the aged and aging. Gerontologist. 1972 Summer;12(2):163–167. [PubMed]
  • Glosser G, Wexler D, Balmelli M. Physicians' and families' perspectives on the medical management of dementia. J Am Geriatr Soc. 1985 Jun;33(6):383–391. [PubMed]
  • Butler RN. Age-ism: another form of bigotry. Gerontologist. 1969 Winter;9(4):243–246. [PubMed]
  • Jones EW. Labeling of the elderly as mentally ill: a community analysis. J Gerontol Nurs. 1982 Apr;8(4):221–224. [PubMed]
  • Lasoski MC, Thelen MH. Attitudes of older and middle-aged persons toward mental health intervention. Gerontologist. 1987 Jun;27(3):288–292. [PubMed]
Articles from CMAJ : Canadian Medical Association Journal are provided here courtesy of
Canadian Medical Association

Links